ONKI3 | Medical Subject Headings

The ONKI is provided as a part of the ONKI Living Lab - an open lab for testing the latest semantic web technologies in practice, with real users like you. Currently, over 10 000 people are using ONKI each month.

We hope you like the ONKI service and enjoy using it for your purposes!

If you encounter any problems or have improvement ideas, please contact the ONKI team. We are also very much interested in your success stories in using ONKI - please share your experiences!

The ONKI Team

Jouni Tuominen, Living Lab contact person, APIs, widgets, publishing of ontologies, etc.
Eero Hyvönen, professor, head of research group

Former members: Kim Viljanen, Rami Alatalo.

Building the future of the Semantic Web and beyond.

SeCo's homepage
For the latest semantic news, follow us on Twitter and fan us on Facebook!

How can we help you?

Live presentations about ONKI: what it is? how to use it?
Support for creating and publishing ontologies.
Online technical support for using ONKI.
Co-operation in projects.
And more, please ask.


Hierarchy:	Medical Subject Headings (MeSH) ∟ Amino Acids, Peptides, and Proteins ∟ Peptides ∟ Peptides, Cyclic ∟ Bacitracin 21 coordinate concepts ∟ Alamethicin \| ∟ Amanitins \| ∟ Capreomycin Sulfate \| ∟ Cyclosporins \| ∟ Cyclotides \| ∟ Dactinomycin \| ∟ Daptomycin \| ∟ Depsipeptides \| ∟ Echinomycin \| ∟ Ferrichrome \| ∟ Microcystins \| ∟ Mycobacillin \| ∟ Nanotubes, Peptide \| ∟ Nisin \| ∟ Octreotide \| ∟ Phalloidine \| ∟ Polymyxins \| ∟ Streptogramins \| ∟ Thiostrepton \| ∟ Tyrothricin \| ∟ Viomycin Medical Subject Headings (MeSH) ∟ Polycyclic Compounds ∟ Macrocyclic Compounds ∟ Peptides, Cyclic ∟ Bacitracin 21 coordinate concepts ∟ Alamethicin \| ∟ Amanitins \| ∟ Capreomycin Sulfate \| ∟ Cyclosporins \| ∟ Cyclotides \| ∟ Dactinomycin \| ∟ Daptomycin \| ∟ Depsipeptides \| ∟ Echinomycin \| ∟ Ferrichrome \| ∟ Microcystins \| ∟ Mycobacillin \| ∟ Nanotubes, Peptide \| ∟ Nisin \| ∟ Octreotide \| ∟ Phalloidine \| ∟ Polymyxins \| ∟ Streptogramins \| ∟ Thiostrepton \| ∟ Tyrothricin \| ∟ Viomycin X
Broader terms:	Medical Subject Headings (MeSH) ∟ Amino Acids, Peptides, and Proteins ∟ Peptides ∟ Peptides, Cyclic ∟ Bacitracin Medical Subject Headings (MeSH) ∟ Polycyclic Compounds ∟ Macrocyclic Compounds ∟ Peptides, Cyclic ∟ Bacitracin Peptides, Cyclic > Peptides > Amino Acids, Peptides, and Proteins > Medical Subject Headings (MeSH) Peptides, Cyclic > Macrocyclic Compounds > Polycyclic Compounds > Medical Subject Headings (MeSH) X
Scope note:	A complex of cyclic peptide antibiotics produced by the Tracy-I strain of Bacillus subtilis. The commercial preparation is a mixture of at least nine bacitracins with bacitracin A as the major constituent. It is used topically to treat open infections such as infected eczema and infected dermal ulcers. (From Goodman and Gilman, The Pharmacological Basis of Therapeutics, 8th ed, p1140) X
activeMeSHYear*:	2006 \| 2007X
dateCreated*:	1999-01-01X
dateRevised*:	2005-06-30X
recordAuthorizer*:	sjnX
recordMaintainer*:	CCRX
recordOriginator*:	NLMX
Type:	Concept X
Coordinate terms:	Alamethicin \| Amanitins \| Capreomycin Sulfate \| Cyclosporins \| Cyclotides \| Dactinomycin \| Daptomycin \| Depsipeptides \| Echinomycin \| Ferrichrome \| Microcystins \| Mycobacillin \| Nanotubes, Peptide \| Nisin \| Octreotide \| Phalloidine \| Polymyxins \| Streptogramins \| Thiostrepton \| Tyrothricin \| Viomycin X
URI:	X
Labels and equivalent concepts:	Basitrasiini (fi) Pharmascience Brand of Bacitracin (en, replaced) Pharma Tek Brand of Bacitracin (en, replaced) Reed & Carnrick Brand of Bacitracin (en, replaced) Zeba-Rx (en, replaced) Zinc Bacitracin (en, replaced) Ocumed Brand of Bacitracin (en, replaced) McNeil Brand of Bacitracin (en, replaced) Baci-Rx (en, replaced) Akorn Brand of Bacitracin (en, replaced) Bacitracin Zinc (en, replaced) Ciba Vision Brand of Bacitracin (en, replaced) Lee Brand of Bacitracin (en, replaced) Dioptic Brand of Bacitracin (en, replaced) A.L. Labs Brand of Bacitracin Zinc Salt (en, replaced) Bacitracinum (la-FI, replaced) X
Share:	X